CellCept (Genentech, Inc.)
Welcome to the PulseAid listing for the CellCept drug offered from Genentech, Inc.. This Antimetabolite Immunosuppressant [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Genentech, Inc. |
NON-PROPRIETARY NAME: | Mycophenolate Mofetil hydrochloride |
SUBSTANCE NAME: | MYCOPHENOLATE MOFETIL HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Antimetabolite Immunosuppressant [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1998-08-12 |
END MARKETING DATE: | 0000-00-00 |
CellCept HUMAN PRESCRIPTION DRUG Details:
Item Description | CellCept from Genentech, Inc. |
LABELER NAME: | Genentech, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 500(mg/20mL) |
START MARKETING DATE: | 1998-08-12 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0004-0298_d5f5de2c-01e5-446e-82be-a1e0e6a3e953 |
PRODUCT NDC: | 0004-0298 |
APPLICATION NUMBER: | NDA050758 |
Other MYCOPHENOLATE MOFETIL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: